Zeng Yijun, Lu Xiaowen, Wang Yadan, He Jihong, Cao Hui, Zhang Lushun, Cheng Li
Department of Neurosurgery, The Third Affiliated Hospital of Chengdu Medical College, Chengdu Pidu District People's Hospital, Chengdu, China.
School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Front Oncol. 2025 May 16;15:1586515. doi: 10.3389/fonc.2025.1586515. eCollection 2025.
BACKGROUND: Glioma, a prevalent brain tumor originating from glial cells, exhibits rapid growth, high recurrence, and significant invasiveness. Standard treatments include surgery, radiotherapy, and chemotherapy, yet their effectiveness remains unsatisfactory. Recent studies implicate oxidative stress in promoting glioma cell proliferation and migration, as well as enhancing survival rates, suggesting antioxidant therapy as a potential tumor treatment strategy. OBJECTIVE: The aim of this review is to summarize the research hotspots on antioxidant treatment options for gliomas in the last twelve years and analyze the future trends through bibliometric analysis. METHOD: We collected articles on oxidative stress in gliomas published between January 1, 2013, and April 5, 2025, using the Web of Science (WOS) database. We also visualized and analyzed annual publications, countries, and journals using VOSviewer, Citespace, and pajek. RESULT: The search yielded a total of 1020 publications. Visual analyses show that the number of articles on this topic has increased annually over the last twelve years. Most of the studies came from China, followed by the United States. The three most cited journals were International Journal of Molecular Sciences, Cancer and Frontiers in Oncology. The author who published the most articles on this topic was Wang HD. CONCLUSION: Through a systematic analysis, we found that current research hotspots mainly focus on the dose of reactive oxygen species (ROS) and tumor proliferation, inflammatory response, apoptosis, etc. in relation to oxidative stress. In addition, we analyzed the direction of future research: a possible focus on the treatment of gliomas via 'tumor microenvironment', 'blood-brain barrier', 'anti-inflammatory' and ' ferroptosis induction ' routes.
背景:胶质瘤是一种起源于神经胶质细胞的常见脑肿瘤,具有生长迅速、高复发率和显著侵袭性的特点。标准治疗方法包括手术、放疗和化疗,但其效果仍不尽人意。最近的研究表明,氧化应激促进胶质瘤细胞增殖和迁移,并提高生存率,这表明抗氧化治疗可能是一种潜在的肿瘤治疗策略。 目的:本综述旨在总结过去十二年中胶质瘤抗氧化治疗选择的研究热点,并通过文献计量分析来分析未来趋势。 方法:我们使用科学网(WOS)数据库收集了2013年1月1日至2025年4月5日期间发表的关于胶质瘤氧化应激的文章。我们还使用VOSviewer、Citespace和pajek对年度出版物、国家和期刊进行了可视化和分析。 结果:检索共得到1020篇出版物。可视化分析表明,在过去十二年中,关于该主题的文章数量逐年增加。大多数研究来自中国,其次是美国。被引用次数最多的三种期刊是《国际分子科学杂志》《癌症》和《肿瘤学前沿》。在该主题上发表文章最多的作者是王HD。 结论:通过系统分析,我们发现当前的研究热点主要集中在活性氧(ROS)剂量与肿瘤增殖、炎症反应、细胞凋亡等与氧化应激相关的方面。此外,我们分析了未来的研究方向:可能会聚焦于通过“肿瘤微环境”“血脑屏障”“抗炎”和“诱导铁死亡”途径治疗胶质瘤。
Front Pharmacol. 2024-10-17
J Cancer Res Clin Oncol. 2024-8-30
Heliyon. 2024-12-16
World J Clin Oncol. 2025-2-24
Annu Rev Cancer Biol. 2017-3
Cancer Cell Int. 2024-10-22
Front Immunol. 2023
Biochim Biophys Acta Rev Cancer. 2023-11
J Control Release. 2022-12